Canadian Large Cap Leaders Spli (TSE:NPS - Get Free Report)'s share price rose 1% during mid-day trading on Wednesday . The company traded as high as C$14.25 and last traded at C$14.10. Approximately 938 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 3,261 shares. The stock had previously closed at C$13.96.
Canadian Large Cap Leaders Spli Stock Performance
The stock's 50-day simple moving average is C$13.65 and its 200 day simple moving average is C$12.81. The company has a market capitalization of C$336.34 million and a PE ratio of -130.56.
Canadian Large Cap Leaders Spli Company Profile
(
Get Free Report)
Northern Power Systems Corp. designs, manufactures, and services wind turbine platforms for the distributed wind market worldwide. The company provides 100 kW and 60 kW turbines under the NPS 100 and NPS 60 names. It also offers power converters for battery energy storage applications under the FlexPhase brand; and technical support for its SmartView supervisory control and data acquisition system.
Read More
Before you consider Canadian Large Cap Leaders Spli, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canadian Large Cap Leaders Spli wasn't on the list.
While Canadian Large Cap Leaders Spli currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
